Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2015-02-28
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Antioxidants on Human Macular Pigments
NCT00718653
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients
NCT02136303
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
NCT00121589
Lutein Influence on Macula of Persons Issued From Amd Parents
NCT01269697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sea buckthorn & lutein
Sea buckthorn oil complemented with lutein. Dose: 2 g/day as capsules taken twice/day for 6 months
Sea buckthorn oil & lutein
Standardised sea buckthorn seed and pulp oil complemented with lutein
Placebo
Triglycerides of medium-chain fatty acids. Dose: 2 g/day as capsules taken twice/day for 6 months
Placebo
Triglycerides of medium chain fatty acids
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sea buckthorn oil & lutein
Standardised sea buckthorn seed and pulp oil complemented with lutein
Placebo
Triglycerides of medium chain fatty acids
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* macular changes associated with high blood pressure
* signs of macular degeneration: classes 2, 3 and 4 according to the Rotterdam study (Mol Vis 2012: 657-74)
* severe eye diseases, exluding cataract. The intervention will begina after surgery and recovery from cataract
60 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aromtech Ltd.
INDUSTRY
Turku University Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBEYE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.